Skip to main navigation Skip to search Skip to main content

Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes

  • Runlu Sun
  • , Pu Fang
  • , Jieyu Jiang
  • , Canxia Huang
  • , Junjie Wang
  • , Qi Guo
  • , Hongwei Li
  • , Xiaoying Wu
  • , Xiangkun Xie
  • , Yuan Jiang
  • , Qian Chen
  • , Jinlan Bao
  • , Jingfeng Wang
  • , Hong Wang
  • , Yuling Zhang
  • Sun Yat-Sen University
  • Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology
  • Temple University

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

PURPOSE: Intracellular cholesterol imbalance plays an important role in adipocyte dysfunction of obesity. However, it is unclear whether obesity induced monocyte chemoattractant protein-1 (MCP-1) causes the adipocyte cholesterol imbalance. In this study, we hypothesize that MCP-1 impairs cholesterol efflux of adipocytes to HDL2 and insulin rescues this process.

METHODS: We recruited coronary artery disease (CAD) patients with obesity and overweight to analyze the association between MCP-1 and HDL2-C by Pearson correlation coefficients. We performed [ 3H]-cholesterol efflux assay to demonstrate the effect of MCP-1 and insulin on cholesterol efflux from 3T3-L1 adipocytes to large HDL2 particles. Western blot, RT-qPCR, cell-surface protein assay, and confocal microscopy were performed to determine the regulatory mechanism.

RESULTS: Plasma MCP-1 concentrations were negatively correlated with HDL2-C in CAD patients with obesity and overweight (r = -0.60, p < 0.001). In differentiated 3T3-L1 adipocytes, MCP-1 reduced cholesterol efflux to large HDL2 particles by 55.4% via decreasing ATP-binding cassette A1 (ABCA1), ABCG1, and scavenger receptor class B type I (SR-BI) expression. Intriguingly, insulin rescued MCP-1 mediated-inhibition of cholesterol efflux to HDL2 in an Akt phosphorylation-dependent manner. The rescue efficacy of insulin was 138.2% for HDL2. Moreover, insulin increased mRNA and protein expression of ABCA1, ABCG1, and SR-BI at both transcriptional and translational levels via the PI3K/Akt activation.

CONCLUSIONS: These findings indicate that MCP-1 impairs cholesterol efflux to large HDL2 particles in adipocytes, which is reversed by insulin via the upregulation of ABCA1, ABCG1, and SR-BI. Therefore, insulin might improve cholesterol imbalance by an anti-inflammatory effect in adipocytes.

CLINICAL TRIAL REGISTRATION NUMBER: ChiCTR2000033297; Date of registration: 2020/05/ 27; Retrospectively registered.

Original languageEnglish
Pages (from-to)665-678
Number of pages14
JournalCardiovascular Drugs and Therapy
Volume36
Issue number4
DOIs
StatePublished - Aug 2022

Keywords

  • Adipocytes
  • Cholesterol efflux; large HDL2 particles
  • Insulin
  • MCP-1
  • Cholesterol/metabolism
  • Humans
  • Adipocytes/metabolism
  • Phosphatidylinositol 3-Kinases/metabolism
  • ATP Binding Cassette Transporter, Subfamily G, Member 1/genetics
  • Proto-Oncogene Proteins c-akt/metabolism
  • Scavenger Receptors, Class B/genetics
  • Overweight/metabolism
  • Cholesterol, HDL
  • Chemokine CCL2/metabolism
  • ATP-Binding Cassette Transporters/genetics
  • ATP Binding Cassette Transporter 1/genetics
  • Obesity/drug therapy

Fingerprint

Dive into the research topics of 'Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes'. Together they form a unique fingerprint.

Cite this